Serum Total and Lipid Bound Sialic Acid Levels in Patients With Benign and Nonmelanom Malignant Skin Tumors

It has been reported that sialic acid containing oligosaccharides play an important rolein the adhesion between cancer cells and endothelial cells and metastatic potential of tumorcells is proportional to cell surface sialylation. In the present study, we investigatedwhether there is a change in ser...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Beyhan Çakır, Cemal Aygıt, 1Bendigar Sunar, Selma Süer Gökmen, Cemal Kazezoğlu
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2007
Materias:
Acceso en línea:https://doaj.org/article/a8c429d50b1a4cdd9958ac1679a34daa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a8c429d50b1a4cdd9958ac1679a34daa
record_format dspace
spelling oai:doaj.org-article:a8c429d50b1a4cdd9958ac1679a34daa2021-12-02T13:55:18ZSerum Total and Lipid Bound Sialic Acid Levels in Patients With Benign and Nonmelanom Malignant Skin Tumors0250-46851303-829Xhttps://doaj.org/article/a8c429d50b1a4cdd9958ac1679a34daa2007-05-01T00:00:00Zhttp://www.turkjbiochem.com/2007/017.pdfhttps://doaj.org/toc/0250-4685https://doaj.org/toc/1303-829XIt has been reported that sialic acid containing oligosaccharides play an important rolein the adhesion between cancer cells and endothelial cells and metastatic potential of tumorcells is proportional to cell surface sialylation. In the present study, we investigatedwhether there is a change in serum total and lipid bound sialic acid levels of patientswith benign and non-melanom malignant skin tumors and, evaluated whether the measurementof sialic acid levels may be useful clinically in distinguishing patients with benignskin tumors from those with non-melanom malignant skin tumors. In this study, 27patients with malignant skin tumors (16 men, age 50.78 ± 12.46 years), 39 patients withbenign skin tumors (17 men, age 48.59 ± 16.23 years) were included. Serum total andlipid bound sialic acid determination was performed by the thiobarbituric acid methoddescribed by Warren and, the resorsinol method described by Katopodis, respectively.Student’s T test and Z test were used to analyze the results. The mean serum total andlipid bound sialic acid levels were found to be 63.01 ± 11.89 mg/dl and 15.77 ± 2.44mg/dl, respectively in patients with benign skin tumors; and 65.95 ± 7.30 mg/dl and16.70 ± 3.80 mg/dl, respectively in patients with non-melanom malignant skin tumors.Serum total sialic acid and lipid bound sialic acid of patients with benign skin tumorswere not different from those of patients with non-melanom malignant skin tumors. Thepercentage of lipid bound sialic acid was found to be 25.3 in patients with non-melanommalignant skin tumors, 25 in patients with benign skin tumors. There was no significantdifference between the value of lipid bound sialic acid percentage in these groups. Ourfinding that there is no significant difference between serum total and lipid-bound sialicacid levels of patients with non melanom malignant skin tumors which are not able tometastase and patients with benign skin tumors supports the studies reporting that sialicacids play an important role in metastases.Beyhan ÇakırCemal Aygıt1Bendigar SunarSelma Süer Gökmen,Cemal Kazezoğlu,De GruyterarticleTotal sialic acidlipid bound sialic acidnon melanom malignant skin tumorbenign skin tumor.BiochemistryQD415-436ENTürk Biyokimya Dergisi, Vol 32, Iss 1, Pp 17-21 (2007)
institution DOAJ
collection DOAJ
language EN
topic Total sialic acid
lipid bound sialic acid
non melanom malignant skin tumor
benign skin tumor.
Biochemistry
QD415-436
spellingShingle Total sialic acid
lipid bound sialic acid
non melanom malignant skin tumor
benign skin tumor.
Biochemistry
QD415-436
Beyhan Çakır
Cemal Aygıt
1Bendigar Sunar
Selma Süer Gökmen,
Cemal Kazezoğlu,
Serum Total and Lipid Bound Sialic Acid Levels in Patients With Benign and Nonmelanom Malignant Skin Tumors
description It has been reported that sialic acid containing oligosaccharides play an important rolein the adhesion between cancer cells and endothelial cells and metastatic potential of tumorcells is proportional to cell surface sialylation. In the present study, we investigatedwhether there is a change in serum total and lipid bound sialic acid levels of patientswith benign and non-melanom malignant skin tumors and, evaluated whether the measurementof sialic acid levels may be useful clinically in distinguishing patients with benignskin tumors from those with non-melanom malignant skin tumors. In this study, 27patients with malignant skin tumors (16 men, age 50.78 ± 12.46 years), 39 patients withbenign skin tumors (17 men, age 48.59 ± 16.23 years) were included. Serum total andlipid bound sialic acid determination was performed by the thiobarbituric acid methoddescribed by Warren and, the resorsinol method described by Katopodis, respectively.Student’s T test and Z test were used to analyze the results. The mean serum total andlipid bound sialic acid levels were found to be 63.01 ± 11.89 mg/dl and 15.77 ± 2.44mg/dl, respectively in patients with benign skin tumors; and 65.95 ± 7.30 mg/dl and16.70 ± 3.80 mg/dl, respectively in patients with non-melanom malignant skin tumors.Serum total sialic acid and lipid bound sialic acid of patients with benign skin tumorswere not different from those of patients with non-melanom malignant skin tumors. Thepercentage of lipid bound sialic acid was found to be 25.3 in patients with non-melanommalignant skin tumors, 25 in patients with benign skin tumors. There was no significantdifference between the value of lipid bound sialic acid percentage in these groups. Ourfinding that there is no significant difference between serum total and lipid-bound sialicacid levels of patients with non melanom malignant skin tumors which are not able tometastase and patients with benign skin tumors supports the studies reporting that sialicacids play an important role in metastases.
format article
author Beyhan Çakır
Cemal Aygıt
1Bendigar Sunar
Selma Süer Gökmen,
Cemal Kazezoğlu,
author_facet Beyhan Çakır
Cemal Aygıt
1Bendigar Sunar
Selma Süer Gökmen,
Cemal Kazezoğlu,
author_sort Beyhan Çakır
title Serum Total and Lipid Bound Sialic Acid Levels in Patients With Benign and Nonmelanom Malignant Skin Tumors
title_short Serum Total and Lipid Bound Sialic Acid Levels in Patients With Benign and Nonmelanom Malignant Skin Tumors
title_full Serum Total and Lipid Bound Sialic Acid Levels in Patients With Benign and Nonmelanom Malignant Skin Tumors
title_fullStr Serum Total and Lipid Bound Sialic Acid Levels in Patients With Benign and Nonmelanom Malignant Skin Tumors
title_full_unstemmed Serum Total and Lipid Bound Sialic Acid Levels in Patients With Benign and Nonmelanom Malignant Skin Tumors
title_sort serum total and lipid bound sialic acid levels in patients with benign and nonmelanom malignant skin tumors
publisher De Gruyter
publishDate 2007
url https://doaj.org/article/a8c429d50b1a4cdd9958ac1679a34daa
work_keys_str_mv AT beyhancakır serumtotalandlipidboundsialicacidlevelsinpatientswithbenignandnonmelanommalignantskintumors
AT cemalaygıt serumtotalandlipidboundsialicacidlevelsinpatientswithbenignandnonmelanommalignantskintumors
AT 1bendigarsunar serumtotalandlipidboundsialicacidlevelsinpatientswithbenignandnonmelanommalignantskintumors
AT selmasuergokmen serumtotalandlipidboundsialicacidlevelsinpatientswithbenignandnonmelanommalignantskintumors
AT cemalkazezoglu serumtotalandlipidboundsialicacidlevelsinpatientswithbenignandnonmelanommalignantskintumors
_version_ 1718392398880440320